Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Pournima Navalkele"'
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 1, Pp 20-22 (2022)
Externí odkaz:
https://doaj.org/article/94345b300e754b588fd19937f9eb4849
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2019 (2019)
Anti-E alloimmunization is the third most common cause of neonatal hemolytic disease, typically causing mild to moderate hemolytic anemia. We report an unusual case of severe hydrops fetalis and persistent pulmonary hypertension (PPHN) in a neonate w
Externí odkaz:
https://doaj.org/article/9d69a4b63cf54c0b95bb72f8c6f9d269
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::137cf01c3799e070faf449ec62695a4b
https://doi.org/10.1002/pbc.30296
https://doi.org/10.1002/pbc.30296
Publikováno v:
Journal of Child Science. 11:e327-e330
Stroke-like migraine attacks after radiation therapy (SMART) syndrome is a rare neurological phenomenon characterized by reversible symptoms of headache, seizure, hemiparesis, and visual changes associated with a remote history of cranial irradiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1d7889cba4a7bab90c689420a322513
https://doi.org/10.1055/s-0041-1740466
https://doi.org/10.1055/s-0041-1740466
Publikováno v:
Journal of Neuropathology and Experimental Neurology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae4fd2ac37639360e7ba3cce6a05098
http://europepmc.org/articles/PMC7577515
http://europepmc.org/articles/PMC7577515
Autor:
Mohamed S. AbdelBaki, Christopher L. Tinkle, Girish Dhall, Rebecca Ronsley, Juliette Hukin, Roger J. Packer, Sabine Mueller, Jonathan L. Finlay, Joseph Stanek, Gregory K. Friedman, Kee Kiat Yeo, Tabitha Cooney, Ashley Margol, Lindsey Hoffman, Susan N. Chi, Amar Gajjar, Christina Coleman, Stephanie Villeneuve, Karen Gauvain, Jacob G. Ellen, Michael Fisher, Richard T Graham, Andrea Cappellano, Ute Bartels, Jack Su, Mohammad H Abu-Arja, Pournima Navalkele, John T. Lucas, Nicholas G. Gottardo, Jeffrey C. Allen
Publikováno v:
Pediatr Blood Cancer
BACKGROUND: Central nervous system (CNS) germinomas are treatment-sensitive tumors with excellent survival outcomes. Current treatment strategies combine chemotherapy with radiotherapy (RT) in order to reduce the field and dose of RT. Germinomas orig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6787439c8ee24d73dc8a92f9dd8d8423
https://doi.org/10.1002/pbc.29172
https://doi.org/10.1002/pbc.29172
Publikováno v:
Neuro-Oncology. 24:i33-i33
Diffuse gliomas are one of the most challenging pediatric brain tumors of the current era. The new WHO classification has brought in a paradigm shift in the diagnosis and management of diffuse gliomas. Although these tumors are not surgically resecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c619e13c3f4f8f8615a68587c92a10c
https://doi.org/10.1093/neuonc/noac079.120
https://doi.org/10.1093/neuonc/noac079.120
Autor:
Evan Cantor, Margaret Shatara, Ashley Meyers, Andrea Ogle, Michele McHugh, Stephanie Reiners, Andrew Cluster, Mohamed S Abdelbaki, Pournima Navalkele, Nicole M Brossier
Publikováno v:
Neuro-Oncology. 24:i87-i87
BACKGROUND: MEK inhibitor therapy is increasingly being utilized for the treatment of pediatric tumors, including low-grade glioma, plexiform neurofibroma and Langerhans cell histiocytosis. These drugs are well-tolerated but do have risk of toxicity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11a2662a5458ed10263137ec8ae29fea
https://doi.org/10.1093/neuonc/noac079.318
https://doi.org/10.1093/neuonc/noac079.318
Autor:
Evan Cantor, Sneha Chaturvedi, Stephanie Reiners, Andrea Ogle, Ashley Meyer, Andrew Cluster, Nicole M Brossier, Hetal Dholaria, Dinisha Govender, Sumanth Nagabushan, Johnathan Schwartz, Mohamed S Abdelbaki, Pournima Navalkele, Margaret Shatara
Publikováno v:
Neuro-Oncology. 24:i92-i92
Background: The discovery of the driving oncogenic alterations in pediatric low-grade gliomas (pLGGs) has shifted our focus towards management with targeted therapies, especially in relapsing or progressive disease. Limited data is available on the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::932acfe5ad48e7e110e0e0ed01f41d84
https://doi.org/10.1093/neuonc/noac079.335
https://doi.org/10.1093/neuonc/noac079.335